Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms HSK 38008, HSK-38008, HSK38008 |
Target |
Mechanism AR-v7 inhibitors(androgen receptor splice variant 7 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic castration-resistant prostate cancer | Phase 1 | CN | 12 Apr 2023 | |
Castration-Resistant Prostatic Cancer | IND Approval | CN | 30 Jun 2023 |